MYCOBACTERIUM FORTUITUM INFECTION

MYCOBACTERIUM FORTUITUM INFECTION was reported 185 times

MYCOBACTERIUM FORTUITUM INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimycobacterial [EPC] 25 0.0010
1 Oxazolidinone Antibacterial [EPC] 24 0.0008
2 Aminoglycoside Antibacterial [EPC] 32 0.0007
3 Macrolide Antimicrobial [EPC] 25 0.0005
4 Gonadotropin [EPC] 1 0.0005
5 Glycopeptide Antibacterial [EPC] 24 0.0004
6 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 8 0.0004
7 Antimetabolite Immunosuppressant [EPC] 7 0.0003
8 Thymic Stromal Lymphopoietin Blocker [EPC] 2 0.0003
9 Central Nervous System Stimulant [EPC] 25 0.0003
10 Tetracycline-class Drug [EPC] 19 0.0003
11 Fluoroquinolone Antibacterial [EPC] 31 0.0002
12 Azole Antifungal [EPC] 31 0.0002
13 Antimalarial [EPC] 2 0.0002
14 Human Immunoglobulin G [EPC] 4 0.0002
15 Antiprotozoal [EPC] 2 0.0002
16 Penem Antibacterial [EPC] 6 0.0002
17 Lipid-based Polyene Antifungal [EPC] 2 0.0002
18 Provitamin D2 Compound [EPC] 4 0.0001
19 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
20 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
21 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 9 0.0001
22 Corticosteroid [EPC] 101 0.0001
23 GLP-2 Analog [EPC] 1 0.0001
24 Atypical Antipsychotic [EPC] 27 0.0001
25 Antirheumatic Agent [EPC] 6 0.0001
26 Calcineurin Inhibitor Immunosuppressant [EPC] 7 0.0001
27 Polyene Antifungal [EPC] 2 0.0000
28 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
29 Progesterone [EPC] 1 0.0000
30 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
31 Alkylating Drug [EPC] 10 0.0000
32 Purine Antimetabolite [EPC] 4 0.0000
33 Interleukin-12 Antagonist [EPC] 4 0.0000
34 Interleukin-23 Antagonist [EPC] 4 0.0000
35 Complement Inhibitor [EPC] 2 0.0000
36 Methylxanthine [EPC] 2 0.0000
37 BCL-2 Inhibitor [EPC] 2 0.0000
38 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
39 Rifamycin Antibacterial [EPC] 1 0.0000
40 Folate Analog Metabolic Inhibitor [EPC] 11 0.0000
41 Phosphodiesterase 4 Inhibitor [EPC] 4 0.0000
42 Amide Local Anesthetic [EPC] 2 0.0000
43 Histamine-2 Receptor Antagonist [EPC] 3 0.0000
44 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2 0.0000
45 CD20-directed Cytolytic Antibody [EPC] 7 0.0000
46 Nucleoside Metabolic Inhibitor [EPC] 6 0.0000
47 Prostacycline Vasodilator [EPC] 3 0.0000
48 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
49 Antiarrhythmic [EPC] 2 0.0000
50 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
51 Tumor Necrosis Factor Blocker [EPC] 17 0.0000
52 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
53 Antidote [EPC] 1 0.0000
54 Loop Diuretic [EPC] 7 0.0000
55 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
56 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
57 Cardiac Glycoside [EPC] 1 0.0000
58 Calcium [EPC] 2 0.0000
59 Catecholamine [EPC] 1 0.0000
60 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
61 Anti-IgE [EPC] 1 0.0000
62 Aminosalicylate [EPC] 1 0.0000
63 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
64 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
65 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
66 Sulfonylurea [EPC] 1 0.0000
67 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
68 Kinase Inhibitor [EPC] 4 0.0000
69 Leukocyte Growth Factor [EPC] 1 0.0000
70 Proton Pump Inhibitor [EPC] 4 0.0000
71 Thiazide Diuretic [EPC] 1 0.0000
72 Vitamin C [EPC] 2 0.0000
73 Mood Stabilizer [EPC] 1 0.0000
74 Platinum-based Drug [EPC] 1 0.0000
75 Platelet Aggregation Inhibitor [EPC] 2 0.0000
76 Osmotic Laxative [EPC] 1 0.0000
77 Vitamin D [EPC] 1 0.0000
78 beta-Adrenergic Blocker [EPC] 1 0.0000
79 Vitamin B12 [EPC] 1 0.0000
80 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
81 GLP-1 Receptor Agonist [EPC] 1 0.0000
82 Insulin Analog [EPC] 1 0.0000